<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-----------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act
of 1934
Date of Report (Date of earliest event reported) March 18, 1999
--------------
UNIVEC, INC.
--------------------------------------------------
(Exact name of registrant as specified in charter)
Delaware 0-22413 11-3163455
- --------------------------------------------------------------------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
22 Dubon Court, Farmingdale, New York 11735
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (516) 777-2000
--------------
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report.)
<PAGE>
Item 5. Other Events.
On March 18, 1999, UNIVEC, Inc. (the "Registrant") issued a press
release, a copy of which is annexed to this report as Exhibit 99.
Item 7. Financial Statements and Exhibits.
(c) Exhibit
99. Press Release dated March 18, 1999.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
UNIVEC, INC.
Dated: March 26, 1999 By: /s/ Joel Schoenfeld
Farmingdale, New York ----------------------------
Joel Schoenfeld
Chief Executive Officer
2
<PAGE>
Thursday March 18, 6:19 pm Eastern Time
Company Press Release
UNIVEC Strengthens Executive Team
FARMINGDALE, N.Y.--(BUSINESS WIRE)--March 18, 1999--UNIVEC, INC. (NASDAQ:UNVC -
news) announced today that Dr. Alan Gold, who currently serves as President,
Chief Operating Officer and a Director of the Company, was named Chairman of the
Board of Directors. In addition, Marla Manowitz, CPA, who currently heads the
company's internal accounting department, has been named Chief Financial Officer
replacing interim CFO Martin Jacobson. Mrs. Manowitz will report to John Frank,
CPA, former partner of Coopers and Lybrand, and who serves as a director of
UNIVEC.
In addition, the Company announced today that Chief Executive Officer, Joel
Schoenfeld, has been named in a Federal Grand Jury Indictment alleging
misrepresentation with four other persons in a commercial transaction in 1991.
Dr. Gold stated "this is a matter which allegedly occurred eight years ago and
came as a complete surprise to everyone. Our Board is satisfied that Mr.
Schoenfeld did nothing improper and will be fully exonerated." In a related 1991
Civil Case Mr. Schoenfeld received a full and unconditional release from
liability from the plaintiff without consideration.
"In the meantime Mr. Schoenfeld will continue his duties as CEO of UNIVEC. We
have experienced significant growth during these last twelve months and much of
our success is directly attributable to the efforts of Mr. Schoenfeld."
In addition to the appointments of Dr. Gold and Mrs. Manowitz, Richard Mintz has
been named to the Board of Directors. Mr. Mintz is President of Peristaltic
Technologies, Inc., manufacturers of medical infusion pumps and plastic
disposable catheters, as well as, Vice President and General Manager of A.K.
Allen & Co. Inc./Allen Avionics, Inc., a manufacturer of electronic components
and fluid power products.
UNIVEC develops, manufactures, licenses and markets safety auto-destruct
hypodermic syringes, designed to protect healthcare workers against needle stick
injuries and patients against cross-infection resulting from reused needles and
syringes.
This press release contains Forward-Looking Statements. Statements in this news
release looking forward in time are made pursuant to the safe harbor provisions
of the Private Securities Litigation Reform Act of 1995. Investors are cautioned
that forward-looking statements involve risks and uncertainties. The Company's
actual results could differ materially from those anticipated in the
forward-looking statements as a result of certain factors.
- ---------------------
Contact:
UNIVEC, Inc., Farmingdale
David Gordon, 516/777-2000
